Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zenith HealthcareBOM:530665 -0.31%61 Days Payable is 88.14 as of Jun. 2026, which is 42% above its 10-year median of 62.18. GuruFocus rates BOM:530665 with a GF Score™ of 61/100 and a GF Value™ of ₹3.71 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 926 Drug Manufacturers companies, Zenith Healthcare ranks better than 59.94% on this metric.
The historical rank and industry rank for Zenith Healthcare's Days Payable or its related term are showing as below:
BOM:530665'
s Days Payable Range Over the Past 10 Years
Min: 39.91 Med: 62.18 Max: 107.43
Current: 106.38
During the past 13 years, Zenith Healthcare's highest Days Payable was 107.43. The lowest was 39.91. And the median was 62.18.
BOM:530665's Days Payable is ranked better than 59.94% of 926
companies
in the Drug Manufacturers industry
Industry Median: 88.745
vs BOM:530665: 106.38
Zenith Healthcare's Days Payable
increased
from Jun. 2025 (78.87) to Jun. 2026 (88.14).
It may suggest that Zenith Healthcaredelayed paying its suppliers.
The historical data trend for Zenith Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenith Healthcare Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zenith Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Zenith Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Zenith Healthcare's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenith Healthcare (BOM:530665) has a Days Payable of 88.14 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zenith Healthcare and its competitors. This is 42% above median its historical median of 62.18. Over the past decade, Zenith Healthcare's Days Payable has ranged from 39.91 to 107.43. According to the industry distribution chart, Zenith Healthcare ranks #371 out of 926 companies in the Drug Manufacturers industry, placing it in the top 40.1%.
Is Zenith Healthcare's Days Payable too high?
Zenith Healthcare's current Days Payable of 88.14 is 42% above median its 10-year median of 62.18. Over the past 10 years, this metric has ranged from a low of 39.91 to a high of 107.43. The Drug Manufacturers industry median Days Payable is 88.75. Zenith Healthcare's value of 88.14 is 0.7% below this industry median. Based on the distribution chart, Zenith Healthcare ranks #371 out of 926 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zenith Healthcare has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenith Healthcare's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zenith Healthcare ranks #371 out of 926 companies for Days Payable. This puts Zenith Healthcare in the upper half of its industry. The industry median Days Payable is 88.75. Zenith Healthcare's value of 88.14 is 0.7% below this benchmark. Historically, Zenith Healthcare's own Days Payable has ranged from 39.91 to 107.43 over the past decade. While the company's 10-year median is 62.18 vs. the industry median of 88.75, Zenith Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.75, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenith Healthcare's current Days Payable of 88.14 is 0.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zenith Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenith Healthcare's current Days Payable is 88.14, which is 42% above median its own 10-year median of 62.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Zenith Healthcare (BOM:530665) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹3.71, compared to a current price of ₹3.17 — trading 14.6% below its estimated fair value. The current Days Payable is 88.14, which is 42% above median its 10-year median of 62.18 and 0.7% below the Drug Manufacturers industry median of 88.75. Zenith Healthcare's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zenith Healthcare (BOM:530665), the current Days Payable is 88.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenith Healthcare (BOM:530665) Overvalued in 2026?
Based on GuruFocus' analysis, Zenith Healthcare stock appears to be undervalued.
The current stock price of ₹3.17 is trading 14.6% below its estimated GF Value™ of ₹3.71.
GuruFocus considers Zenith Healthcare to be Modestly Undervalued.
Key valuation signals for BOM:530665:
Days Payable: 88.14 (42% above median its 10-year median of 62.18)
GF Value™: ₹3.71 vs. price of ₹3.17 (14.6% below fair value)
Industry Position: 0.7% below the Drug Manufacturers median (#371 of 926)
No single metric tells the full story. See the BOM:530665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenith Healthcare Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and trading of pharmaceutical formulations. The company also undertakes contracts for manufacturing business. It manufactures pharmaceutical formulations in the form of Tablets, Capsules, Oral liquids, and injectables. The company sells its products in India and also exports internationally.
61GF Score
Get the complete analysis for BOM:530665
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530665 has been successfully added to your 
